Koers VioQuest Pharmaceuticals, Inc. Other OTC
Aandelen
VOQP
US9276252023
Biotechnologie & Medisch Onderzoek
Omzet 2006 | - | Omzet 2007 | - | Marktkapitalisatie | 5,46 mln. 5,05 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | -8 mln. -7,4 mln. | Nettowinst (verlies) 2007 | -10 mln. -9,25 mln. | EV/omzet 2006 | - |
Nettoliquiditeiten 2006 | 2,67 mln. 2,47 mln. | Nettoschuld 2007 | 2,24 mln. 2,07 mln. | EV/omzet 2007 | - |
K/w-verhouding 2006 |
-2,5
x | K/w-verhouding 2007 |
-0,43
x | Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark D. Dacko
AUD | Comptroller/Controller/Auditor | 72 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | 09-02-09 | |
Mark D. Dacko
AUD | Comptroller/Controller/Auditor | 72 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,79% | 115 mld. | |
+11,65% | 106 mld. | |
-6,20% | 24,69 mld. | |
-2,33% | 21,97 mld. | |
-6,03% | 19,27 mld. | |
-13,41% | 17,56 mld. | |
-40,50% | 17,32 mld. | |
+6,64% | 14,03 mld. | |
+31,84% | 12,13 mld. |